DNER and cancer: To provide a proof of concept for the usefulness of our cell culture model for evaluating cancer therapies, in the present study we evaluated a well-known BET bromodomain inhibitor, JQ1, which has been shown to favorably modulate the cancer epigenome to overcome therapy resistance in many leukemias and solid cancers [16,17,18,19,20,21].